Effect of Statin and Angiotensin-converting Enzyme Inhibition on Structural and Hemodynamic Alterations in Autosomal Dominant Polycystic Kidney Disease Model.
From: University of Colorado School of Medicine, 4200 East Ninth Ave., B173, Denver, CO 80262, USA.
American journal of physiology. Renal physiology
- Publish Date: Sep 2007
- ISSN: 0363-6127
- Volume: 293
- Issue: 3
- Pages: F854-9
- Medium: Print
- Language: English
- Citation (JAMA): Zafar Iram, Tao Yunxia, Falk Sandor, et al. Effect of Statin and Angiotensin-converting Enzyme Inhibition on Structural and Hemodynamic Alterations in Autosomal Dominant Polycystic Kidney Disease Model.. Am. J. Physiol. Renal Physiol. Sep 2007;293:F854-9
Abstract
Autosomal dominant polycystic kidney disease (ADPKD) is the most common life-threatening hereditary disease and is the fourth most common cause of end-stage kidney disease. Preclinical studies to identify effective interventions to prevent or slow progression of PKD nephropathy are therefore direly needed. Heterozygous Han:SPRD rats are an autosomal dominant PKD model with many of the characteristics of ADPKD in humans. In the present study, parameters known to antedate the decrease in renal function, namely, renal structure, renal blood flow (RBF), and mean arterial pressure (MAP), were evaluated with three different interventions, namely, HMG-CoA reductase inhibition with lovastatin, angiotensin-converting enzyme (ACE) inhibition with enalapril, and a combination of these two treatments. The statin therapy demonstrated structural and functional benefits, including increased RBF and decreased BUN, independently of a change in MAP, while the ACE inhibition therapy demonstrated structural benefit in association with a decrease in MAP. An enhancement of these protective interventions in this autosomal dominant PKD model was not demonstrated with the combined treatment.
Mesh Headings (Keywords): Angiotensin-Converting Enzyme Inhibitors, Animals, Enalapril, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hypertension, Kidney, Lovastatin, Male, Organ Size, Polycystic Kidney, Autosomal Dominant, Renal Circulation
Check for Full Text / PubMed Unique Identifier (PMID): 17581927
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.